Retrospective Analysis of Efficacy and Safety of Tocilizumab Treatment in Patients with Severe Systemic-Onset Juvenile Idiopathic Arthritis Followed for 12 Months

Table 2

Characteristics of previous therapy in patients with sJIA at the moment of enrollment in the study.

Drug	Dose; (median (25; 75))	Number of children
Methotrexate, mg/m^2/week	19 (15; 24)	25
Methotrexate, mg/m^2/week +	17 (15; 23)
Cyclosporine, mg/kg/day	4 (4; 4)	47
Methotrexate, mg/m^2/week +	12
Mycophenolate mofetil, mg/day	1000	1
Methotrexate, mg/m^2/week +	15
Leflunomide	20	2
Prednisolone, mg/day	9.5 (6.5; 12)	44
NSAIDs	—	75
Rituximab	—	22
Infliximab	—	17
Adalimumab	—	6
Etanercept	—	2
Number of biologics
3 products	—	5
2 products	—	10
1 product	—	14